Beatrice C. Thomas

Cincinnati Children's Hospital Medical Center

Also affiliated with Southeastern University, Nova Southeastern University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “A Precision Medicine Drug Discovery Pipeline Identifies Combined CDK2 and 9 Inhibition as a Novel Therapeutic Strategy in Colorectal Cancer”.

A Precision Medicine Drug Discovery Pipeline Identifies Combined CDK2 and 9 Inhibition as a Novel Therapeutic Strategy in Colorectal Cancer

Molecular Cancer Therapeutics(2020)10.1158/1535-7163.mct-20-0454

N/A

0.550DataRank · unranked

38 citations

Roham Salman Roghani, Ali Sanjari Moghaddam, Beatrice C. Thomas, Gabrielle Rupprecht, Kathryn E. Ware +8 more

Convergent evolution of p38/MAPK activation in hormone resistant prostate cancer mediates pro-survival, immune evasive, and metastatic phenotypes

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.04.22.050385

N/A

0DataRank · unranked

14 citations

Santosh Gupta, Jared Eng, Gabor Kemeny, Bhairavy Puviindran, Wen‐Chi Foo +18 more

A synthetic lethal screen for Snail-induced enzalutamide resistance identifies JAK/STAT signaling as a therapeutic vulnerability in prostate cancer

Frontiers in Molecular Biosciences(2023)10.3389/fmolb.2023.1104505

N/A

0DataRank · unranked

9 citations

Beatrice C. Thomas, Pelumi Olawuni, Maya U. Sheth, Nathan Hawkey, M. Yeshwanth +7 more